High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Status:
Recruiting
Trial end date:
2032-11-01
Target enrollment:
Participant gender:
Summary
This is an international multicenter, open-label, randomized phase III trial including three
sequential randomizations to assess efficacy of induction and consolidation chemotherapies
and radiotherapy for patients with high-risk neuroblastoma.